A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes (BOOST™: JAPAN)
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes (BOOST™: JAPAN)
This trial is conducted in Japan. The aim of this trial is to investigate the efficacy and safety of NN5401 (insulin degludec/insulin aspart) with insulin glargine in subjects with type 2 diabetes in Japan. Depending on pre-trial oral anti-diabetic drugs (OADs), subjects continued at the same dose and dosing frequency.
Inclusion Criteria:
Exclusion Criteria:
Asahikawa-shi, Hokkaido, 070 0002, Japan
Chuo-ku, Tokyo, 103 0002, Japan
Chuo-ku, Tokyo, 103 0027, Japan
Ebina-shi, 243 0432, Japan
Fukuoka-shi, Fukuoka, 815 8555, Japan
Kamakura-shi, 247 0056, Japan
Katsushika-ku, Tokyo, 125 0054, Japan
Kumamoto-shi, Kumamoto, 861 8045, Japan
Kumamoto-shi,Kumamoto, 862 0976, Japan
Kyoto-shi, Kyoto, 615 8125, Japan
Naka-shi, Ibaraki, 311 0113, Japan
Nishinomiya-shi, Hygo, 662 0971, Japan
Obihiro-shi, Hokkaido, 080 0016, Japan
Obihiro-shi, Hokkaido, 080 0848, Japan
Ota-ku, Tokyo, 144 0035, Japan
Sappro-shi, Hokkaido, 060 8648, Japan
Tamana-shi, Kumamoto, 865 0064, Japan
Urasoe-shi,, 901 2104, Japan
Yokohama-shi, Kanagawa, 227 0054, Japan